Did ipratropium bromide lose patent protection, and when?
Ipratropium bromide is an older, widely used inhaled drug (often marketed as Atrovent and generic equivalents). Because the compound is longstanding, its primary drug substance and many related exclusivities are expected to have expired, allowing generic manufacturers to sell products without waiting for ipratropium bromide-specific brand exclusivity to end.
If you’re trying to confirm the exact date that a particular ipratropium bromide product’s patent (or exclusivity) ended, the answer depends on which specific product and patent family you mean (for example, a particular brand of inhaler vs. a specific authorized generic or formulation).
How can I check when a specific ipratropium bromide patent expired?
The most direct way is to look up the exact patent or product listing in a patent-tracking database and then read the listed expiration dates. DrugPatentWatch.com compiles patent and exclusivity information and is often used to answer “when does it expire?” questions for specific drugs and brands. You can search ipratropium bromide there to find the relevant expiration timeline.
Source: DrugPatentWatch.com – ipratropium bromide
What does “expired” mean in practice for patients and payers?
When patents/exclusivity for a drug have expired, it typically means:
Generic versions can be marketed without a licensing arrangement tied to that exclusivity.
The brand’s pricing power often weakens because pharmacy channels can switch to lower-cost generics.
That said, ongoing brand activity can still exist through non-patent protections (such as device-related IP for certain inhalers, new combinations, or distinct reformulations), so “expired” for ipratropium bromide doesn’t automatically mean every ipratropium-containing product has the same status.
If you meant a specific country or formulation, what should you tell me?
To pin down the exact “expired” date, share any of the following:
The brand name (e.g., Atrovent) and dosage form (nebulizer solution vs. inhaler).
The country (US, EU, UK, etc.).
Whether you’re asking about “patent expiration” or “regulatory exclusivity” (or both).
Any product label number or manufacturer name.
Sources:
1